Clinical trial
A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To…
NCT00273416 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00273416 |
|---|---|
| Title | A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses |
| Official title | A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses Of PF-00592379 On Erectile Function, Using 100mg Sildenafil As A Positive Control |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Impotence |
| Intervention type | Drug |
| Interventions | PF-00592379, Sildenafil 100mg |
| Enrollment | 32 |
| Start date | Jan 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 24, 2006 |
| Countries | Norway, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: